China-US Health Regulatory Dialogue In Crosshairs Amid Biden-Xi Summit
PIC/S Membership Meets Political Pressure
Beijing’s application to join an international pharma inspections scheme offers a rare opportunity to revitalize a largely downsized US-China dialogue, but domestic pressure and public opinion may jeopardize the opportunity.
